EP3862428A4 - Verfahren zur verlängerung des telomers einer zelle - Google Patents

Verfahren zur verlängerung des telomers einer zelle Download PDF

Info

Publication number
EP3862428A4
EP3862428A4 EP19868942.4A EP19868942A EP3862428A4 EP 3862428 A4 EP3862428 A4 EP 3862428A4 EP 19868942 A EP19868942 A EP 19868942A EP 3862428 A4 EP3862428 A4 EP 3862428A4
Authority
EP
European Patent Office
Prior art keywords
cell
telomere
extending
extending telomere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19868942.4A
Other languages
English (en)
French (fr)
Other versions
EP3862428B1 (de
EP3862428A1 (de
Inventor
Yong Seung Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemon Inc
Original Assignee
Stemon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemon Inc filed Critical Stemon Inc
Priority claimed from PCT/KR2019/011681 external-priority patent/WO2020071652A1/ko
Publication of EP3862428A1 publication Critical patent/EP3862428A1/de
Publication of EP3862428A4 publication Critical patent/EP3862428A4/de
Application granted granted Critical
Publication of EP3862428B1 publication Critical patent/EP3862428B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C12N5/063—Kereatinocyte stem cells; Keratinocyte progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C12N2521/10—Sound, e.g. ultrasounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP19868942.4A 2018-10-02 2019-09-10 Verfahren zur verlängerung des telomers einer zelle Active EP3862428B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180117265 2018-10-02
KR1020190108764A KR102209234B1 (ko) 2018-10-02 2019-09-03 세포의 텔로미어를 신장시키는 방법
PCT/KR2019/011681 WO2020071652A1 (ko) 2018-10-02 2019-09-10 세포의 텔로미어를 신장시키는 방법

Publications (3)

Publication Number Publication Date
EP3862428A1 EP3862428A1 (de) 2021-08-11
EP3862428A4 true EP3862428A4 (de) 2021-11-10
EP3862428B1 EP3862428B1 (de) 2024-02-28

Family

ID=70292168

Family Applications (2)

Application Number Title Priority Date Filing Date
EP19868942.4A Active EP3862428B1 (de) 2018-10-02 2019-09-10 Verfahren zur verlängerung des telomers einer zelle
EP19869268.3A Pending EP3862429A4 (de) 2018-10-02 2019-09-19 Zusammensetzung zur verlängerung des telomers einer zelle und herstellungsverfahren dafür

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP19869268.3A Pending EP3862429A4 (de) 2018-10-02 2019-09-19 Zusammensetzung zur verlängerung des telomers einer zelle und herstellungsverfahren dafür

Country Status (2)

Country Link
EP (2) EP3862428B1 (de)
KR (2) KR102209234B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3945132A1 (de) 2020-07-29 2022-02-02 Konkuk University Industry- Academic Cooperation Foundation Mikrofluidisches system, verfahren zur hemmung, verzögerung oder umkehrung der zellulären seneszenz unter verwendung eines mikrofluidischen systems und so erhaltene zelle
WO2022032337A1 (en) * 2020-08-11 2022-02-17 Royal Melbourne Institute Of Technology Stimulating cellular production of exosomes
KR102674715B1 (ko) * 2023-10-06 2024-06-13 휴먼바이오텍 주식회사 줄기세포의 텔로미어의 길이를 신장시키는 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066247A2 (en) * 2004-12-17 2006-06-22 Exvivo Technologies Methods and compositions for extending telomere length and increasing cell lifespan
WO2016000075A1 (en) * 2014-07-03 2016-01-07 Dan Grebenisan System and method for increasing the length of telomeres
WO2018057542A1 (en) * 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2437606T (lt) * 2009-05-18 2016-10-10 Telomerase Activation Sciences, Inc. Kompozicijos ir būdai skirti didinti telomerazės aktyvumą
JP2016514953A (ja) * 2013-02-22 2016-05-26 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー テロメア伸長に関する化合物、組成物、方法及びキット
KR101632108B1 (ko) * 2013-07-03 2016-06-27 서울대학교병원 인간 세포의 줄기세포능을 증대시키는 방법
EP3380102A4 (de) * 2015-11-25 2019-05-08 The Methodist Hospital System Telomerverlängerung und entzündungshemmende mittel zur zellregenerierung
KR102050852B1 (ko) * 2016-03-11 2019-12-03 주식회사 스템온 세포 리프로그래밍 장치
KR101855967B1 (ko) * 2016-03-11 2018-05-10 가톨릭관동대학교산학협력단 물리적 자극에 의한 환경유입을 이용한 세포 리프로그래밍 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066247A2 (en) * 2004-12-17 2006-06-22 Exvivo Technologies Methods and compositions for extending telomere length and increasing cell lifespan
WO2016000075A1 (en) * 2014-07-03 2016-01-07 Dan Grebenisan System and method for increasing the length of telomeres
WO2018057542A1 (en) * 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BROCK J. SISHC ET AL: "Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis", FRONTIERS IN ONCOLOGY, vol. 5, 24 November 2015 (2015-11-24), pages 1 - 19, XP055586183, DOI: 10.3389/fonc.2015.00257 *
NEUHOF D ET AL: "Telomerase activity and telomere length in human lymphoblasts after irradiation", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, USA, vol. 48, no. 3, 1 January 2000 (2000-01-01), pages 276, XP027402761, ISSN: 0360-3016, [retrieved on 20000101] *
V KH KHAVINSON ET AL: "Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells", BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 135, no. 6, 1 June 2003 (2003-06-01), US, pages 590 - 592, XP055579199, ISSN: 0007-4888, DOI: 10.1023/A:1025493705728 *

Also Published As

Publication number Publication date
KR102209234B1 (ko) 2021-02-01
EP3862428B1 (de) 2024-02-28
EP3862429A4 (de) 2021-11-10
EP3862428A1 (de) 2021-08-11
KR20200038172A (ko) 2020-04-10
KR20200038180A (ko) 2020-04-10
EP3862429A2 (de) 2021-08-11
KR102228136B1 (ko) 2021-03-17

Similar Documents

Publication Publication Date Title
IL276600A (en) Methods for producing T cells
EP3375028A4 (de) Verfahren zur vorbereitung einer kathode für eine sekundärbatterie
EP3561918A4 (de) Prälithiationsverfahren für eine anode für eine sekundärbatterie
EP3545569A4 (de) Verfahren zur herstellung einer anodenaufschlämmung für eine sekundärbatterie
EP3743082A4 (de) Verfahren zur verwendung für car-t-zellen
EP3472173A4 (de) Beschichtungen für bauteile elektrochemischer zellen
EP3254320A4 (de) Verfahren zur herstellung von anoden für lithiumbatterien
EP3824080A4 (de) Verfahren zur analyse von zellen
EP3751001A4 (de) Verfahren zur herstellung von ergothionin
EP3604216A4 (de) Herstellungsverfahren für festelektrolyt mit li3ps4
EP3605703A4 (de) Herstellungsverfahren für festelektrolyt auf lgps-basis
EP3783727A4 (de) Verfahren zur aktivierung einer sekundärbatterie
EP3491177A4 (de) Verfahren zur elektrochemischen abscheidung
EP3573163A4 (de) Verfahren zur herstellung einer monozelle
EP3862428A4 (de) Verfahren zur verlängerung des telomers einer zelle
EP3868889A4 (de) Verfahren zur aktivierung/proliferation von t-zellen
EP3778902A4 (de) Zellproduktionsverfahren
EP3843580A4 (de) Verfahren zum entwurf von einlegesohlen
IL274746A (en) A method for cell culture
EP3842522A4 (de) Verfahren zur herstellung von regulatorischen t-zellen
EP3831931A4 (de) Zellproduktionsverfahren
EP3747991A4 (de) Verfahren zur induktion von zellen
EP3508569A4 (de) Verfahren zur herstellung von mikroglia aus pluripotenten stammzellen
EP3846924A4 (de) Verfahren zur kontinuierlichen zellkultur
EP3808839A4 (de) Verfahren zur herstellung von transformierten zellen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20211011

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/077 20100101ALI20211005BHEP

Ipc: C12N 13/00 20060101AFI20211005BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220808

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20231115

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019047513

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240628

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20240228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240228

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240528

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240228